Beyond Herceptin and Gleevec
- 4 July 2003
- journal article
- review article
- Published by Elsevier in Current Opinion in Chemical Biology
- Vol. 7 (4) , 490-495
- https://doi.org/10.1016/s1367-5931(03)00082-6
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Clinical translation of angiogenesis inhibitorsNature Reviews Cancer, 2002
- Influence of Unrecognized Molecular Heterogeneity on Randomized Clinical TrialsJournal of Clinical Oncology, 2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- EGFR and cancer prognosisPublished by Elsevier ,2001
- Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or AmplificationScience, 2001
- Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia ChromosomeNew England Journal of Medicine, 2001
- New Insights into the Interaction of Ras with the Plasma MembraneCell, 1999
- Monoclonal antibody therapy of human cancer: Taking the HER2 protooncogene to the clinicJournal of Clinical Immunology, 1991
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987
- Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cellsNature, 1984